Weekly Report: Hipgnosis Songs Fund Is Melting Down — What Comes Next for the Formerly High-Flying IP Investor?

Late last month, following several far-from-ideal developments for Hipgnosis Songs Fund (HSF), investors voted overwhelmingly against the Merck Mercuriadis-founded operation’s continuation. In this in-depth report, we look at what led to the fund’s current predicament and what may come next. In our latest DMN Pro weekly analytical report, we take a closer look at the […]